Repetitive transcranial magnetic stimulation for specific patient populations: clinical and cost-effectiveness and safety
CADTH
Record ID 32014000231
English
Authors' recommendations:
Overall, for patients with depression, there appears to be a significant improvement with rTMS treatment of duration >2 weeks or >10 sessions when compared to sham. For patients with auditory hallucination or obsessive compulsive disorder there appears to be no significant improvement with rTMS treatment of duration >2 weeks or >10 sessions when compared to sham. No relevant evidence was identified for rTMS treatment for substance use disorders.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/jan-2013/RC0417%20rTMS-Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Cost-Benefit Analysis
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.